Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug cocktail aims to fight advanced liver cancer

NCT ID NCT03755791

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 study tests whether a combination of cabozantinib (a targeted therapy) and atezolizumab (an immunotherapy) works better than the standard drug sorafenib for people with advanced liver cancer who haven't had prior systemic treatment. About 837 adults are taking part. The goal is to see if the combo can slow cancer growth and extend survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cabozantinib (a targeted therapy) plus atezolizumab (an immunotherapy)
What this could lead to
If successful, this combination could offer a new first-line treatment option for advanced liver cancer, potentially improving how long patients live without their cancer growing.
What could go wrong
This is a large phase 3 trial, but the combination may not prove better than the current standard sorafenib. Side effects from the drugs, such as fatigue, high blood pressure, or immune-related reactions, are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

837 people

The number who actually took part.

Started

Jun 2018

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Histological or cytological diagnosis of HCC or clinical diagnosis of HCC in cirrhotic patients by Computed Tomography (CT) or Computed Tomography (MRI) per the American Association for the Study of Liver Diseases (AASLD) 2018 or European Association for the Study of the Liver (EASL) 2018 guidelines. * The participant has disease that is not amenable to a curative treatment approach (eg, transplant, surgery, ablation therapy) or locoregional therapy (eg, TACE). * Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as determined by the Investigator. * Barcelona Clinic Liver Cancer (BCLC) stage Category B or C. * Child-Pugh Score of A. * Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Key Exclusion Criteria: * Known fibrolamellar carcinoma, sarcomatoid HCC or mixed hepatocellular cholangiocarcinoma. * Prior systemic anticancer therapy for advanced HCC including but not limited to chemotherapy, small molecule kinase inhibitors, and immune checkpoint inhibitors (ICIs). Participants who have received local intratumoral or arterial chemotherapy are eligible; local anticancer therapy within ≥ 28 days before randomization * Radiation therapy for bone metastasis within 2 weeks, any other radiation therapy within 8 weeks prior to randomization. * Known brain metastases or cranial epidural disease unless adequately treated with radiotherapy and/or surgery (including radiosurgery) and stable for at least 8 weeks prior to randomization. * Concomitant anticoagulation with oral anticoagulants Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hepatocellular carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Exelixis Clinical Site #1

    Las Vegas, Nevada, 89169, United States

  • Exelixis Clinical Site #10

    Prague, 140 59, Czechia

  • Exelixis Clinical Site #101

    Murmansk, 183047, Russia

  • Exelixis Clinical Site #102

    Liège, 4000, Belgium

  • Exelixis Clinical Site #103

    Barcelona, 08908, Spain

  • Exelixis Clinical Site #104

    Seoul, 03080, South Korea

  • Exelixis Clinical Site #105

    Seoul, 03080, South Korea

  • Exelixis Clinical Site #106

    Singapore, 169610, Singapore

  • Exelixis Clinical Site #107

    Box Hill, Victoria, 3128, Australia

  • Exelixis Clinical Site #108

    Moscow, 115478, Russia

  • Exelixis Clinical Site #109

    San Francisco, California, 94115, United States

  • Exelixis Clinical Site #11

    Kansas City, Missouri, 64128, United States

  • Exelixis Clinical Site #110

    Sankt Gallen, 9007, Switzerland

  • Exelixis Clinical Site #111

    Saint Petersburg, 197758, Russia

  • Exelixis Clinical Site #112

    Los Angeles, California, 90033, United States

  • Exelixis Clinical Site #113

    Curitiba, Paraná, 81520-060, Brazil

  • Exelixis Clinical Site #114

    Busan, 49241, South Korea

  • Exelixis Clinical Site #115

    Basel, 4031, Switzerland

  • Exelixis Clinical Site #116

    Singapore, 308433, Singapore

  • Exelixis Clinical Site #117

    Pasig, 1605, Philippines

  • Exelixis Clinical Site #118

    Cebu City, 6000, Philippines

  • Exelixis Clinical Site #119

    Changhua, 500, Taiwan

  • Exelixis Clinical Site #12

    Chapel Hill, North Carolina, 27599-7600, United States

  • Exelixis Clinical Site #120

    Chicago, Illinois, 60637, United States

  • Exelixis Clinical Site #121

    Jaú, São Paulo, 17210-120, Brazil

  • Exelixis Clinical Site #122

    Dnipro, 49102, Ukraine

  • Exelixis Clinical Site #123

    Kharkiv, 61070, Ukraine

  • Exelixis Clinical Site #124

    Odesa, 65055, Ukraine

  • Exelixis Clinical Site #125

    Chernivtsi, 58013, Ukraine

  • Exelixis Clinical Site #126

    Kogarah, New South Wales, 2217, Australia

  • Exelixis Clinical Site #127

    Suwon, Gyeonggi-do, 16499, South Korea

  • Exelixis Clinical Site #128

    Taipei, 10491, Taiwan

  • Exelixis Clinical Site #129

    London, England, W12 0HS, United Kingdom

  • Exelixis Clinical Site #13

    Seattle, Washington, 98101, United States

  • Exelixis Clinical Site #130

    Montería, Departamento de Córdoba, 230002, Colombia

  • Exelixis Clinical Site #131

    Novara, 28100, Italy

  • Exelixis Clinical Site #132

    Monterrey, Nuevo León, 64000, Mexico

  • Exelixis Clinical Site #133

    Mexico City, 06700, Mexico

  • Exelixis Clinical Site #134

    San Luis Potosí City, 78250, Mexico

  • Exelixis Clinical Site #135

    León, Guanajuato, 37000, Mexico

  • Exelixis Clinical Site #136

    Quezon City, 1102, Philippines

  • Exelixis Clinical Site #137

    Sankt Pölten, Lower Austria, 3100, Austria

  • Exelixis Clinical Site #138

    Uzhhorod, 88000, Ukraine

  • Exelixis Clinical Site #139

    Hat Yai, Changwat Songkhla, 90110, Thailand

  • Exelixis Clinical Site #14

    New Brunswick, New Jersey, 08903, United States

  • Exelixis Clinical Site #140

    Budapest, 1083, Hungary

  • Exelixis Clinical Site #141

    Tuxtla Gutiérrez, Chiapas, 29038, Mexico

  • Exelixis Clinical Site #142

    Greenslopes, Queensland, 4120, Australia

  • Exelixis Clinical Site #143

    Chiang Mai, 50200, Thailand

  • Exelixis Clinical Site #144

    Charleston, South Carolina, 29425, United States

  • Exelixis Clinical Site #145

    Tainan, 736, Taiwan

  • Exelixis Clinical Site #146

    Hong Kong, Hong Kong

  • Exelixis Clinical Site #147

    Milan, 20122, Italy

  • Exelixis Clinical Site #148

    Ghent, 9000, Belgium

  • Exelixis Clinical Site #149

    Naples, 80131, Italy

  • Exelixis Clinical Site #15

    Mysłowice, Silesian Voivodeship, 41-400, Poland

  • Exelixis Clinical Site #150

    Klagenfurt, Carinthia, 9020, Austria

  • Exelixis Clinical Site #151

    London, England, NW3 2QG, United Kingdom

  • Exelixis Clinical Site #152

    Brescia, 25124, Italy

  • Exelixis Clinical Site #153

    Veracruz, 94300, Mexico

  • Exelixis Clinical Site #154

    Houston, Texas, 77030, United States

  • Exelixis Clinical Site #155

    Westmead, New South Wales, 2145, Australia

  • Exelixis Clinical Site #156

    São Paulo, São Paulo, 01321-001, Brazil

  • Exelixis Clinical Site #157

    Goyang-si, Gyeonggi-do, 10408, South Korea

  • Exelixis Clinical Site #158

    Bologna, 40138, Italy

  • Exelixis Clinical Site #159

    Tucson, Arizona, 85719, United States

  • Exelixis Clinical Site #16

    Lyon, 69317, France

  • Exelixis Clinical Site #160

    Mexico City, 06760, Mexico

  • Exelixis Clinical Site #161

    Taichung, 407, Taiwan

  • Exelixis Clinical Site #162

    Kaohsiung City, 833, Taiwan

  • Exelixis Clinical Site #163

    Tricase, Lecce, 73039, Italy

  • Exelixis Clinical Site #164

    Madrid, 28007, Spain

  • Exelixis Clinical Site #165

    Darlinghurst, New South Wales, 2010, Australia

  • Exelixis Clinical Site #166

    Heidelberg, Victoria, 3084, Australia

  • Exelixis Clinical Site #167

    Roma, 00168, Italy

  • Exelixis Clinical Site #168

    Valencia, 46009, Spain

  • Exelixis Clinical Site #169

    Edegem, 2650, Belgium

  • Exelixis Clinical Site #17

    Kurralta Park, South Australia, Australia

  • Exelixis Clinical Site #170

    Dublin, 8, Ireland

  • Exelixis Clinical Site #171

    Kingswood, New South Wales, 2747, Australia

  • Exelixis Clinical Site #172

    Bern, 3010, Switzerland

  • Exelixis Clinical Site #173

    Edirne, 22030, Turkey (Türkiye)

  • Exelixis Clinical Site #174

    Vienna, 1090, Austria

  • Exelixis Clinical Site #175

    Barretos, São Paulo, 14784-400, Brazil

  • Exelixis Clinical Site #176

    Portland, Oregon, 97213, United States

  • Exelixis Clinical Site #177

    Torino, 10126, Italy

  • Exelixis Clinical Site #178

    Ankara, 06230, Turkey (Türkiye)

  • Exelixis Clinical Site #179

    Istanbul, 34214, Turkey (Türkiye)

  • Exelixis Clinical Site #18

    Hradec Králové, 500 05, Czechia

  • Exelixis Clinical Site #180

    Malatya, 44280, Turkey (Türkiye)

  • Exelixis Clinical Site #181

    São Paulo, São Paulo, 04538-132, Brazil

  • Exelixis Clinical Site #182

    Torino, 10128, Italy

  • Exelixis Clinical Site #183

    Khon Kaen, 40002, Thailand

  • Exelixis Clinical Site #184

    Salvador, Estado de Bahia, 40110-060, Brazil

  • Exelixis Clinical Site #185

    Nanjing, Jiangsu, 210002, China

  • Exelixis Clinical Site #186

    São Paulo, São Paulo, 01246-900, Brazil

  • Exelixis Clinical Site #187

    São Paulo, São Paulo, 01509-010, Brazil

  • Exelixis Clinical Site #188

    Leuven, 3000, Belgium

  • Exelixis Clinical Site #189

    Istanbul, Instanbul, 34098, Turkey (Türkiye)

  • Exelixis Clinical Site #19

    Temple, Texas, 76508, United States

  • Exelixis Clinical Site #190

    Nedlands, Western Australia, 6009, Australia

  • Exelixis Clinical Site #191

    Miami, Florida, 33125, United States

  • Exelixis Clinical Site #192

    Manchester, England, M20 4BX, United Kingdom

  • Exelixis Clinical Site #193

    Ankara, 06010, Turkey (Türkiye)

  • Exelixis Clinical Site #194

    Hamilton, Ontario, L8V 5C2, Canada

  • Exelixis Clinical Site #195

    Chicago, Illinois, 60612, United States

  • Exelixis Clinical Site #196

    Belfast, Northern Ireland, BT9 7AB, United Kingdom

  • Exelixis Clinical Site #197

    Tainan, 704, Taiwan

  • Exelixis Clinical Site #198

    Graz, Styria, 8036, Austria

  • Exelixis Clinical Site #199

    Dallas, Texas, 75246, United States

  • Exelixis Clinical Site #2

    Rialto, California, 92377, United States

  • Exelixis Clinical Site #20

    Pessac, 33604, France

  • Exelixis Clinical Site #200

    Orange, California, 92868-3201, United States

  • Exelixis Clinical Site #201

    Rosario, Santa Fe Province, S2000CVB, Argentina

  • Exelixis Clinical Site #202

    Cluj-Napoca, Cluj, 400641, Romania

  • Exelixis Clinical Site #203

    Porto Alegre, Rio Grande do Sul, 90050-170, Brazil

  • Exelixis Clinical Site #204

    Cluj-Napoca, Cluj, 400015, Romania

  • Exelixis Clinical Site #205

    Edmonton, Alberta, T6G 2B7, Canada

  • Exelixis Clinical Site #206

    Bucharest, 022328, Romania

  • Exelixis Clinical Site #207

    San Diego, California, 92093, United States

  • Exelixis Clinical Site #208

    Phoenix, Arizona, 85004, United States

  • Exelixis Clinical Site #209

    Iași, 700483, Romania

  • Exelixis Clinical Site #21

    Majadahonda, Madrid, 28222, Spain

  • Exelixis Clinical Site #210

    Kassel, Hesse, 34125, Germany

  • Exelixis Clinical Site #211

    Cluj-Napoca, Cluj, 400015, Romania

  • Exelixis Clinical Site #212

    Ottawa, Ontario, K1H 8L6, Canada

  • Exelixis Clinical Site #213

    City of Buenos Aires, Buenos Aires, C1199ABB, Argentina

  • Exelixis Clinical Site #214

    Berlin, 13125, Germany

  • Exelixis Clinical Site #215

    Hamburg, 20246, Germany

  • Exelixis Clinical Site #216

    City of Buenos Aires, Buenos Aires, C1264AAA, Argentina

  • Exelixis Clinical Site #217

    City of Buenos Aires, Buenos Aires, C1118AAT, Argentina

  • Exelixis Clinical Site #218

    Hangzhou, Zhejiang, 310016, China

  • Exelixis Clinical Site #219

    Pilar, Buenos Aires, B1629ODT, Argentina

  • Exelixis Clinical Site #22

    Majadahonda, Madrid, 28222, Spain

  • Exelixis Clinical Site #220

    Rosario, Santa Fe Province, 2000, Argentina

  • Exelixis Clinical Site #221

    Nanchang, Jiangxi, 330006, China

  • Exelixis Clinical Site #222

    Halifax, Nova Scotia, B3H 2Y9, Canada

  • Exelixis Clinical Site #223

    Hangzhou, Zhejiang, 310022, China

  • Exelixis Clinical Site #224

    Changsha, Hunan, 410013, China

  • Exelixis Clinical Site #225

    Xiamen, Fujian, 361004, China

  • Exelixis Clinical Site #226

    Linyi, Shandong, 276000, China

  • Exelixis Clinical Site #227

    Harbin, Heilongjiang, 150081, China

  • Exelixis Clinical Site #228

    Fuzhou, Fujian, 350014, China

  • Exelixis Clinical Site #229

    Changchun, Jilin, 130021, China

  • Exelixis Clinical Site #23

    Grenoble, 38043, France

  • Exelixis Clinical Site #230

    Zhengzhou, Henan, 450008, China

  • Exelixis Clinical Site #231

    Changsha, Hunan, 410008, China

  • Exelixis Clinical Site #232

    Shanghai, 201305, China

  • Exelixis Clinical Site #233

    Hefei, Anhui, 230036, China

  • Exelixis Clinical Site #234

    Jiangyin, Jiansu, 214400, China

  • Exelixis Clinical Site #235

    Chengdu, Sichuan, 610041, China

  • Exelixis Clinical Site #236

    Shenyang, Liaoning, 110006, China

  • Exelixis Clinical Site #237

    Beijing, 100050, China

  • Exelixis Clinical Site #238

    Nanchang, Jiangxi, 330006, China

  • Exelixis Clinical Site #24

    Gdansk, Pomeranian Voivodeship, 80-952, Poland

  • Exelixis Clinical Site #242

    Guangzhou, Guangdong, 510280, China

  • Exelixis Clinical Site #243

    Udine, 33100, Italy

  • Exelixis Clinical Site #244

    Frankfurt am Main, Hesse, 60590, Germany

  • Exelixis Clinical Site #246

    Changchun, Jilin, 130012, China

  • Exelixis Clinical Site #25

    Debrecen, 4032, Hungary

  • Exelixis Clinical Site #26

    Szeged, 6720, Hungary

  • Exelixis Clinical Site #27

    Besançon, 25030, France

  • Exelixis Clinical Site #28

    Santander, Cantabria, 39008, Spain

  • Exelixis Clinical Site #29

    Caen, 14033, France

  • Exelixis Clinical Site #3

    Spokane, Washington, 99208, United States

  • Exelixis Clinical Site #30

    Jerusalem, 9112001, Israel

  • Exelixis Clinical Site #31

    Montbéliard, 25250, France

  • Exelixis Clinical Site #32

    Vandœuvre-lès-Nancy, 54511, France

  • Exelixis Clinical Site #33

    Petah Tikva, 4941492, Israel

  • Exelixis Clinical Site #34

    Winnipeg, Manitoba, R3E 0V9, Canada

  • Exelixis Clinical Site #35

    Rehovot, 7661041, Israel

  • Exelixis Clinical Site #36

    Utrecht, 3584 CX, Netherlands

  • Exelixis Clinical Site #37

    Olomouc, 779 00, Czechia

  • Exelixis Clinical Site #38

    Prague, 150 06, Czechia

  • Exelixis Clinical Site #39

    Toledo, Ohio, 43614, United States

  • Exelixis Clinical Site #4

    Atlanta, Georgia, 30318, United States

  • Exelixis Clinical Site #40

    Ramat Gan, 5262101, Israel

  • Exelixis Clinical Site #41

    Warsaw, Masovian Voivodeship, 02-507, Poland

  • Exelixis Clinical Site #42

    Hong Kong, Hong Kong

  • Exelixis Clinical Site #43

    Amiens, 80054, France

  • Exelixis Clinical Site #44

    La Jolla, California, 92037, United States

  • Exelixis Clinical Site #45

    Zaragoza, 50009, Spain

  • Exelixis Clinical Site #46

    Seattle, Washington, 98109, United States

  • Exelixis Clinical Site #47

    Nantes, 44093, France

  • Exelixis Clinical Site #48

    Clichy, 92110, France

  • Exelixis Clinical Site #49

    Montpellier, 34295, France

  • Exelixis Clinical Site #5

    Kansas City, Missouri, 64131, United States

  • Exelixis Clinical Site #50

    Brussels, California, 1070, Belgium

  • Exelixis Clinical Site #51

    Nice, 06202, France

  • Exelixis Clinical Site #52

    Amsterdam, North Holland, 1105 AZ, Netherlands

  • Exelixis Clinical Site #53

    Rozzano, Milano, 20089, Italy

  • Exelixis Clinical Site #54

    San Francisco, California, 94158, United States

  • Exelixis Clinical Site #55

    Lille, 59037, France

  • Exelixis Clinical Site #56

    Bondy, 93140, France

  • Exelixis Clinical Site #57

    Haine-Saint-Paul, 7100, Belgium

  • Exelixis Clinical Site #58

    Washington D.C., District of Columbia, 20007, United States

  • Exelixis Clinical Site #59

    Pamplona, Navarre, 31008, Spain

  • Exelixis Clinical Site #6

    Baltimore, Maryland, 21202, United States

  • Exelixis Clinical Site #60

    Grafton, Auckland, 1023, New Zealand

  • Exelixis Clinical Site #61

    Zurich, 8091, Switzerland

  • Exelixis Clinical Site #62

    Newton, Wellington Region, 6021, New Zealand

  • Exelixis Clinical Site #63

    Madrid, 28046, Spain

  • Exelixis Clinical Site #64

    Linz, Upper Austria, 4010, Austria

  • Exelixis Clinical Site #65

    Brussels, 1200, Belgium

  • Exelixis Clinical Site #66

    Tbilisi, 0112, Georgia

  • Exelixis Clinical Site #67

    Tbilisi, 0144, Georgia

  • Exelixis Clinical Site #68

    Tbilisi, 0114, Georgia

  • Exelixis Clinical Site #69

    Batumi, 6000, Georgia

  • Exelixis Clinical Site #7

    Burlington, Massachusetts, 01805, United States

  • Exelixis Clinical Site #70

    Tbilisi, 0186, Georgia

  • Exelixis Clinical Site #71

    Calgary, Alberta, T2N 4N2, Canada

  • Exelixis Clinical Site #72

    Parkville, Victoria, 3050, Australia

  • Exelixis Clinical Site #73

    Sochi, 354057, Russia

  • Exelixis Clinical Site #74

    Kislino, Kursk Oblast, 305524, Russia

  • Exelixis Clinical Site #75

    Incheon, 22332, South Korea

  • Exelixis Clinical Site #76

    Albuquerque, New Mexico, 87131, United States

  • Exelixis Clinical Site #77

    Busan, 47392, South Korea

  • Exelixis Clinical Site #78

    Camperdown, New South Wales, 2050, Australia

  • Exelixis Clinical Site #79

    Seoul, 06273, South Korea

  • Exelixis Clinical Site #8

    St Louis, Missouri, 63110, United States

  • Exelixis Clinical Site #80

    Nizhny Novgorod, 603137, Russia

  • Exelixis Clinical Site #81

    Kaluga, 248007, Russia

  • Exelixis Clinical Site #82

    Taipei, 10002, Taiwan

  • Exelixis Clinical Site #83

    Bristol, England, BS2 8ED, United Kingdom

  • Exelixis Clinical Site #84

    Rotterdam, South Holland, 3015 GD, Netherlands

  • Exelixis Clinical Site #85

    Montreal, Quebec, H3T 1E2, Canada

  • Exelixis Clinical Site #86

    Busan, 49201, South Korea

  • Exelixis Clinical Site #87

    Cambridge, England, CB2 0QQ, United Kingdom

  • Exelixis Clinical Site #88

    Philadelphia, Pennsylvania, 19107, United States

  • Exelixis Clinical Site #89

    Belo Horizonte, Minas Gerais, 30110-022, Brazil

  • Exelixis Clinical Site #9

    Hong Kong, Hong Kong

  • Exelixis Clinical Site #90

    Saint Petersburg, 197758, Russia

  • Exelixis Clinical Site #91

    São Paulo, 04543-000, Brazil

  • Exelixis Clinical Site #92

    Maastricht, Limburg, 6229 HX, Netherlands

  • Exelixis Clinical Site #93

    Seoul, 06351, South Korea

  • Exelixis Clinical Site #94

    Taoyuan, 333, Taiwan

  • Exelixis Clinical Site #95

    Krasnodar, 350040, Russia

  • Exelixis Clinical Site #96

    Pathum Wan, Bangkok, 10330, Thailand

  • Exelixis Clinical Site #97

    Singapore, 217562, Singapore

  • Exelixis Clinical Site #98

    Belo Horizonte, Minas Gerais, 30130-090, Brazil

  • Exelixis Clinical Site #99

    Seoul, 05505, South Korea

  • Exelixis Site #239

    Beijing, 100034, China

  • Exelixis Site #240

    Shanghai, 200001, China

  • Exelixis Site #241

    Changsha, Hunan, 410013, China

  • Exelixisi Clinical Site #100

    Taipei, 11217, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.